首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antibacterial activities of N-substituted-glycinyl 1H-1,2,3-triazolyl oxazolidinones
【24h】

Synthesis and antibacterial activities of N-substituted-glycinyl 1H-1,2,3-triazolyl oxazolidinones

机译:N-取代的甘氨酰基1H-1,2,3-三唑基恶唑烷酮的合成及抑菌活性

获取原文
获取原文并翻译 | 示例
       

摘要

A series of 1H-1,2,3-triazolyl piperazino oxazolidinone analogs with optionally varied glycinyl substitutions were synthesized and their antibacterial activity assessed against a panel of susceptible and resistant Gram-positive and selected Gram-negative bacteria including clinical isolates. The N-aroyl- and N-heteroaroyl-glycinyl (MIC: 0.06-4 μg/ml) derivatives were more potent than the N-acylglycinyl (2-8 μg/ml) derivatives against all Gram-positive bacteria tested. Nitro substitution on aryl and heteroaryl rings significantly enhanced activity against Gram-positive bacteria, as noted with the 3,5-dinitrobenzoyl (6m and 6n) and 5-nitro-2-furoyl (6u and 6v) derivatives with MIC ranges of and 0.25-0.5 and 0.06-0.5 μg/ml, respectively. These nitro analogs also showed more potent extended activity against Moraxella catarrhalis, with MICs ranges of 0.25-1 μg/ml, compared to linezolid (MIC: 8 μg/ml). Hence, the presence of the N-aroyl and/or N-heteroaroyl glycinyl structural motifs as spacer group could significantly enhance the antibacterial activities of 1H-1,2,3-triazolyl oxazolidinone class of compounds.
机译:合成了一系列具有可选变化的甘氨酰基取代基的1H-1,2,3-三唑基哌嗪子基恶唑烷酮类似物,并评估了其对一组敏感和耐药的革兰氏阳性细菌和选定的革兰氏阴性细菌(包括临床分离株)的抗菌活性。对于所有测试的革兰氏阳性细菌,N-芳酰基和N-杂芳酰基-甘氨酰衍生物(MIC:0.06-4μg/ ml)比N-酰基甘氨酰衍生物(2-8μg/ ml)更有效。如3,5-二硝基苯甲酰基(6m和6n)和5-硝基-2-呋喃基(6u和6v)衍生物的MIC范围分别为0.25和0.25,芳基和杂芳基环上的硝基取代显着增强了对革兰氏阳性细菌的活性。分别为-0.5和0.06-0.5μg/ ml。与利奈唑胺(MIC:8μg/ ml)相比,这些硝基类似物还显示出更有效的针对卡他莫拉氏菌的扩展活性,MIC范围为0.25-1μg/ ml。因此,作为间隔基的N-芳酰基和/或N-杂芳酰基甘氨酰基结构基序的存在可以显着增强1H-1,2,3-三唑基恶唑烷酮类化合物的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号